Reeder Robinson to Molecular Targeted Therapy
This is a "connection" page, showing publications Reeder Robinson has written about Molecular Targeted Therapy.
Connection Strength
0.196
-
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. Cancer Chemother Pharmacol. 2022 05; 89(5):643-653.
Score: 0.196
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.